$VCEL News

Vericel (NASDAQ:VCEL): Strong Growth Backed by a Constructive Technical Setup

Vericel to Report Third Quarter 2026 Financial Results on November 5, 2026

Truist Securities Maintains Buy on Vericel, Lowers Price Target to $52

Vericel (VCEL) Stock Looks Fully Priced After A 31% Gain

Vericel Corporation (VCEL) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript

Vericel: MACI And Regenerative Knee Cartilage

Vericel to Present at the 24th Annual Morgan Stanley Global Healthcare Conference on Tuesday, September 15, 2026

Vericel (NASDAQ:VCEL) Stands Out on the Affordable Growth Screen

Vericel (NASDAQ:VCEL): A Strong Growth Play With an Improving Technical Setup

Vericel Corp (NASDAQ:VCEL): Growth at a Reasonable Price

TD Cowen Maintains Buy on Vericel, Raises Price Target to $58

Truist Securities Reiterates Buy on Vericel, Raises Price Target to $58

Vericel Corporation 2026 Q2 - Results - Earnings Call Presentation

HC Wainwright & Co. Maintains Buy on Vericel, Raises Price Target to $72

Vericel Q2 Earnings Call Highlights

Vericel Corporation (VCEL) Beats Q2 Earnings and Revenue Estimates

Vericel (NASDAQ:VCEL) Beats Q2 Estimates, Raises Guidance, Shares Rise

Vericel Corporation (VCEL) Q2 2026 Earnings Call Transcript

Vericel Reports Second Quarter 2026 Financial Results, Raises Full-Year Financial Guidance and Announces Share Repurchase Program

Vericel Q2 EPS $0.04 Beats $(0.03) Estimate, Sales $77.457M Beat $72.689M Estimate